Oncology Institute Long Term Debt 2020-2025 | TOI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Oncology Institute long term debt from 2020 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Oncology Institute long term debt from 2020 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$138.3B
CVS Health (CVS)	$80.7B
Elevance Health (ELV)	$77.8B
Cencora (COR)	$57.7B
DiDi Global (DIDIY)	$28.9B
Labcorp Holdings (LH)	$20.6B
Natera (NTRA)	$20.3B
BioMerieux (BMXMF)	$16.9B
EUROFINS SCIENT (ERFSF)	$13.9B
CochLear (CHEOY)	$12.8B
Solventum (SOLV)	$12.6B
ICON (ICLR)	$11.6B
Revvity (RVTY)	$11.2B
Viatris (VTRS)	$10.7B
Medpace Holdings (MEDP)	$9B
Sonic Healthcare (SKHHY)	$8.8B
Avantor (AVTR)	$8.8B
HealthEquity (HQY)	$8.4B
Caris Life Sciences,�Inc (CAI)	$8B
Charles River Laboratories (CRL)	$7.6B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$4.9B
BrightSpring Health Services (BTSG)	$3.5B
Sotera Health (SHC)	$3.2B
Surgery Partners (SGRY)	$2.9B
Alignment Healthcare (ALHC)	$2.6B
Concentras Parent (CON)	$2.5B
Organon (OGN)	$2.5B
GeneDx Holdings (WGS)	$2.3B
Progyny (PGNY)	$2B